Prof. Dr. med. Pietro Vernazza
A single-nucleotide polymorphism in the sterol-regulatory element-binding protein 1c gene is predictive of HIV-related hyperlipoproteinaemia
Miserez A, Muller P, Barella L, Schwietert M, Erb P, Vernazza P, Battegay M, Swiss HIV Cohort Study. A single-nucleotide polymorphism in the sterol-regulatory element-binding protein 1c gene is predictive of HIV-related hyperlipoproteinaemia. AIDS (London, England) 2001; 15:2045-9.
19.10.2001A single-nucleotide polymorphism in the sterol-regulatory element-binding protein 1c gene is predictive of HIV-related hyperlipoproteinaemia
19.10.2001AIDS (London, England) 2001; 15:2045-9
Miserez A R, Muller P Y, Barella L, Schwietert M, Erb P, Vernazza Pietro, Battegay M, Swiss HIV Cohort Study
Disseminated M. avium complex infection in the Swiss HIV Cohort Study: declining incidence, improved prognosis and discontinuation of maintenance therapy
Rossi M, Furrer H, Rickenbach M, Weber R, Bernasconi E, Vernazza P, Bucher H, Egloff N, Schiffer V, Telenti A, Flepp M, Swiss HIV Cohort Study. Disseminated M. avium complex infection in the Swiss HIV Cohort Study: declining incidence, improved prognosis and discontinuation of maintenance therapy. Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2001; 131:471-7.
11.08.2001Disseminated M. avium complex infection in the Swiss HIV Cohort Study: declining incidence, improved prognosis and discontinuation of maintenance therapy
11.08.2001Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2001; 131:471-7
Rossi M, Furrer H, Rickenbach M, Weber R, Bernasconi E, Vernazza Pietro, Bucher H, Egloff N, Schiffer V, Telenti A, Flepp M, Swiss HIV Cohort Study
Long-term evaluation of T-cell subset changes after effective combination antiretroviral therapy during asymptomatic HIV-infection
Bisset L, Opravil M, Grob P, Weber R, Dubs R, Vernazza P, Battegay M, Fischer M, Cone R, Swiss HIV Cohort Study. Long-term evaluation of T-cell subset changes after effective combination antiretroviral therapy during asymptomatic HIV-infection. Journal of acquired immune deficiency syndromes (1999) 2001; 27:266-71.
01.07.2001Long-term evaluation of T-cell subset changes after effective combination antiretroviral therapy during asymptomatic HIV-infection
01.07.2001Journal of acquired immune deficiency syndromes (1999) 2001; 27:266-71
Bisset L R, Opravil M, Grob P J, Weber R, Dubs R W, Vernazza Pietro, Battegay M, Fischer M, Cone R W, Swiss HIV Cohort Study
HIV transmission after suspension of highly active antiretroviral therapy
Bernasconi E, Vernazza P, Bernasconi A, Hirschel B, Swiss HIV Cohort Study. HIV transmission after suspension of highly active antiretroviral therapy. Journal of acquired immune deficiency syndromes (1999) 2001; 27:209.
01.06.2001HIV transmission after suspension of highly active antiretroviral therapy
01.06.2001Journal of acquired immune deficiency syndromes (1999) 2001; 27:209
Bernasconi E, Vernazza Pietro, Bernasconi A, Hirschel B, Swiss HIV Cohort Study
Longitudinal sero-reactivity to human herpesvirus 8 (KSHV) in the Swiss HIV Cohort 4.7 years before KS
Quinlivan E, Wang R, Stewart P, Kolmoltri C, Regamey N, Erb P, Vernazza P, Swiss HIV Cohort Study. Longitudinal sero-reactivity to human herpesvirus 8 (KSHV) in the Swiss HIV Cohort 4.7 years before KS. Journal of medical virology 2001; 64:157-66.
01.06.2001Longitudinal sero-reactivity to human herpesvirus 8 (KSHV) in the Swiss HIV Cohort 4.7 years before KS
01.06.2001Journal of medical virology 2001; 64:157-66
Quinlivan E B, Wang R X, Stewart P W, Kolmoltri C, Regamey N, Erb P, Vernazza Pietro, Swiss HIV Cohort Study
Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model
Chakraborty H, Krieger J, Coombs R, Patterson B, Eron J, Fiscus S, Vernazza P, Helms R, Sen P, Cohen M. Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model. AIDS (London, England) 2001; 15:621-7.
30.03.2001Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model
30.03.2001AIDS (London, England) 2001; 15:621-7
Chakraborty H, Krieger J N, Coombs R W, Patterson B K, Eron J J, Fiscus S A, Vernazza Pietro, Helms R W, Sen P K, Cohen M S
A randomised prospective study to evaluate a rapid HIV-antibody assay in the management of cases of percutaneous exposure amongst health care workers
King A, Osterwalder J, Vernazza P. A randomised prospective study to evaluate a rapid HIV-antibody assay in the management of cases of percutaneous exposure amongst health care workers. Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2001; 131:10-3.
12.01.2001A randomised prospective study to evaluate a rapid HIV-antibody assay in the management of cases of percutaneous exposure amongst health care workers
12.01.2001Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2001; 131:10-3
King A M, Osterwalder J J, Vernazza Pietro
Combined therapy with saquinavir, ritonavir and stavudine in moderately to severely immunosuppressed HIV-infected protease inhibitor-naive patients
Battegay M, Hirschel B, Bedoucha V, Morgenthaler S, Jaccard C, Malinverni R, Erb P, Sendi P, Flepp M, Bernasconi E, Vernazza P, Swiss HIV Cohort Study. Combined therapy with saquinavir, ritonavir and stavudine in moderately to severely immunosuppressed HIV-infected protease inhibitor-naive patients. HIV medicine 2001; 2:35-42.
01.01.2001Combined therapy with saquinavir, ritonavir and stavudine in moderately to severely immunosuppressed HIV-infected protease inhibitor-naive patients
01.01.2001HIV medicine 2001; 2:35-42
Battegay M, Hirschel B, Bedoucha V, Morgenthaler S, Jaccard C, Malinverni R, Erb P, Sendi P, Flepp M, Bernasconi E, Vernazza Pietro, Swiss HIV Cohort Study
Alternative strategies for anti-HIV treatment
Eron J, Vernazza P. Alternative strategies for anti-HIV treatment. AIDS (London, England) 2001; 15 Suppl 5:S161-9.
01.01.2001Alternative strategies for anti-HIV treatment
01.01.2001AIDS (London, England) 2001; 15 Suppl 5:S161-9
Eron J J, Vernazza Pietro
Sensitization to human immunodeficiency virus in seronegative exposed partners
Vernazza P, Kahlert C, Fierz W. Sensitization to human immunodeficiency virus in seronegative exposed partners. The Journal of infectious diseases 2000; 182:1810-2.
01.12.2000Sensitization to human immunodeficiency virus in seronegative exposed partners
01.12.2000The Journal of infectious diseases 2000; 182:1810-2
Vernazza Pietro, Kahlert Christian, Fierz W
[Cause of death and autopsy findings in patients of the Swiss HIV Cohort Study (SHCS)]
Semela D, Glatz M, Hunziker D, Schmid U, Vernazza P. [Cause of death and autopsy findings in patients of the Swiss HIV Cohort Study (SHCS)]. Schweizerische medizinische Wochenschrift 2000; 130:1726-33.
11.11.2000[Cause of death and autopsy findings in patients of the Swiss HIV Cohort Study (SHCS)]
11.11.2000Schweizerische medizinische Wochenschrift 2000; 130:1726-33
Semela David, Glatz M, Hunziker D, Schmid U, Vernazza Pietro
Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infection. Swiss HIV Cohort Study
Rutschmann O, Perrin L, Leduc D, Fagard C, Bernasconi E, Malinverni R, Telenti A, Ledergerber B, Opravil M, Bucher H, Vernazza P, Hirschel B. Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infection. Swiss HIV Cohort Study. AIDS (London, England) 2000; 14:2145-51.
29.09.2000Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infection. Swiss HIV Cohort Study
29.09.2000AIDS (London, England) 2000; 14:2145-51
Rutschmann O T, Perrin L, Leduc D, Fagard C, Bernasconi E, Malinverni R, Telenti A, Ledergerber B, Opravil M, Bucher H C, Vernazza Pietro, Hirschel B
Cervical squamous intraepithelial lesions in HIV-infected women: prevalence, incidence and regression. European Study Group on Natural History of HIV Infection in Women
Delmas M, Vernazza P, Suligoi B, Sperandeo D, Savonius H, Peña J, Meier F, van den Hoek A, Anzén B, Poveda J, Bergeron C, Hamers F, van Benthem B, Larsen C, Brunet J. Cervical squamous intraepithelial lesions in HIV-infected women: prevalence, incidence and regression. European Study Group on Natural History of HIV Infection in Women. AIDS (London, England) 2000; 14:1775-84.
18.08.2000Cervical squamous intraepithelial lesions in HIV-infected women: prevalence, incidence and regression. European Study Group on Natural History of HIV Infection in Women
18.08.2000AIDS (London, England) 2000; 14:1775-84
Delmas M C, Vernazza Pietro, Suligoi B, Sperandeo D, Savonius H, Peña J M, Meier F, van den Hoek A, Anzén B, Poveda J D, Bergeron C, Hamers F F, van Benthem B, Larsen C, Brunet J B
[HIV superinfection: myth or reality?]
Vernazza P, Bernasconi E, Hirschel B. [HIV superinfection: myth or reality?]. Schweizerische medizinische Wochenschrift 2000; 130:1101-4.
08.08.2000[HIV superinfection: myth or reality?]
08.08.2000Schweizerische medizinische Wochenschrift 2000; 130:1101-4
Vernazza Pietro, Bernasconi E, Hirschel B
Performance of five different assays for the quantification of viral load in persons infected with various subtypes of HIV-1. Swiss HIV Cohort Study
Bürgisser P, Vernazza P, Flepp M, Böni J, Tomasik Z, Hummel U, Pantaleo G, Schüpbach J. Performance of five different assays for the quantification of viral load in persons infected with various subtypes of HIV-1. Swiss HIV Cohort Study. Journal of acquired immune deficiency syndromes (1999) 2000; 23:138-44.
01.02.2000Performance of five different assays for the quantification of viral load in persons infected with various subtypes of HIV-1. Swiss HIV Cohort Study
01.02.2000Journal of acquired immune deficiency syndromes (1999) 2000; 23:138-44
Bürgisser P, Vernazza Pietro, Flepp M, Böni J, Tomasik Z, Hummel U, Pantaleo G, Schüpbach J
Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV Cohort Study
Vernazza P, Fiscus S, Cohen M, Boggian K, Roth F, Schock J, Cone R, Flepp M, Troiani L, Eron J. Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV Cohort Study. AIDS (London, England) 2000; 14:117-21.
28.01.2000Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV Cohort Study
28.01.2000AIDS (London, England) 2000; 14:117-21
Vernazza Pietro, Fiscus S A, Cohen M S, Boggian K, Roth F, Schock J, Cone R W, Flepp M J, Troiani L, Eron J J
Effects of early antiretroviral treatment on HIV-1 RNA in blood and lymphoid tissue: a randomized trial of double versus triple therapy. Swiss HIV Cohort Study
Opravil M, Lüthy R, Roos M, Knuchel M, Huber W, Ott P, Bisset L, Lorenzi P, Bassetti S, Vernazza P, Fischer M, Cone R, Weber R. Effects of early antiretroviral treatment on HIV-1 RNA in blood and lymphoid tissue: a randomized trial of double versus triple therapy. Swiss HIV Cohort Study. Journal of acquired immune deficiency syndromes (1999) 2000; 23:17-25.
01.01.2000Effects of early antiretroviral treatment on HIV-1 RNA in blood and lymphoid tissue: a randomized trial of double versus triple therapy. Swiss HIV Cohort Study
01.01.2000Journal of acquired immune deficiency syndromes (1999) 2000; 23:17-25
Opravil M, Lüthy R, Roos M, Knuchel M C, Huber W, Ott P, Bisset L R, Lorenzi P, Bassetti S, Vernazza Pietro, Fischer M, Cone R W, Weber R
Prevalence of hepatitis C infection in Malawi and lack of association with sexually transmitted diseases
Maida M, Daly C, Hoffman I, Cohen M, Kumwenda M, Vernazza P. Prevalence of hepatitis C infection in Malawi and lack of association with sexually transmitted diseases. European journal of epidemiology 2000; 16:1183-4.
01.01.2000Prevalence of hepatitis C infection in Malawi and lack of association with sexually transmitted diseases
01.01.2000European journal of epidemiology 2000; 16:1183-4
Maida M J, Daly C C, Hoffman I, Cohen M S, Kumwenda M, Vernazza Pietro
[HIV 1999: suppression at what price?]
Vernazza P. [HIV 1999: suppression at what price?]. Schweizerische medizinische Wochenschrift 1999; 129:2010-3.
28.12.1999[HIV 1999: suppression at what price?]
28.12.1999Schweizerische medizinische Wochenschrift 1999; 129:2010-3
Vernazza Pietro
Uniform risk of clinical progression despite differences in utilization of highly active antiretroviral therapy: Swiss HIV Cohort Study
Junghans C, Low N, Chan P, Witschi A, Vernazza P, Egger M. Uniform risk of clinical progression despite differences in utilization of highly active antiretroviral therapy: Swiss HIV Cohort Study. AIDS (London, England) 1999; 13:2547-54.
24.12.1999Uniform risk of clinical progression despite differences in utilization of highly active antiretroviral therapy: Swiss HIV Cohort Study
24.12.1999AIDS (London, England) 1999; 13:2547-54
Junghans C, Low N, Chan P, Witschi A, Vernazza Pietro, Egger M